SS
BMRN icon

Sunbelt Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sunbelt Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.41K Sell
78
-20
-20% -$1.17K ﹤0.01% 1719
2025
Q4 		$5.82K Buy
98
+70
+250% +$3.81K ﹤0.01% 1594
2025
Q3 		$1.52K Buy
+28
New +$1.6K ﹤0.01% 1944
2024
Q4 		– Sell
-14
Closed -$984 – 1819
2024
Q3 		$984 Buy
+14
New +$1.17K ﹤0.01% 1682

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sunbelt Securities's BMRN Position: Q1 2026 in Review

Sunbelt Securities reduced its BioMarin Pharmaceuticals (BMRN) stake by 20% in Q1 2026, selling an estimated $1.17K and leaving 78 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

Sunbelt Securities first reported a position in BMRN in Q3 2024 and has held it in 4 quarters since. The position peaked at $5.82K in Q4 2025. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Sunbelt Securities held 78 shares of BioMarin Pharmaceuticals worth $4.41K as of Q1 2026.
  • Sunbelt Securities sold 20 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $1.17K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1719 holding.
  • Sunbelt Securities first reported a position in BioMarin Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Sunbelt Securities's BioMarin Pharmaceuticals position peaked at $5.82K in Q4 2025.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.